Clinical trials
Not yet recruiting Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
190 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 10 |
| 2024 | 16 |
| 2025 | 45 |
| 2026 | 108 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 190 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 9 |
| The First Affiliated Hospital with Nanjing Medical University | 5 |
| Ruijin Hospital | 4 |
| Sun Yat-sen University | 4 |
| Zhujiang Hospital | 4 |
| National Taiwan University Hospital | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 2 |
| Chinese PLA General Hospital | 2 |
| Dana-Farber Cancer Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 190 |
| Multiple Myeloma | 14 |
| Lymphoma, B-Cell | 12 |
| Neoplasm Metastasis | 12 |
| Leukemia, Myeloid, Acute | 11 |
| Neoplasms | 11 |
| Lymphoma | 9 |
| Uterine Cervical Neoplasms | 9 |
| Carcinoma, Hepatocellular | 6 |
| Hematologic Neoplasms | 6 |
Trials
Showing 26 to 50 of 190. Each trial links to its page on Pharma Observatory.
90 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.